50th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180353419 | A SPRAYABLE GEL COMPOSITION AND USE THEREOF | 2018-12-13 |
20180353420 | COMPOSITIONS CONTAINING POLYCARBODIIMIDES AND LATEX POLYMERS FOR TREATING KERATINOUS SUBSTRATES | 2018-12-13 |
20180353421 | CLEAR COAT FORMULATIONS FOR USE OVER NAIL POLISH | 2018-12-13 |
20180353422 | Compositions For Dental Varnishes And Methods Of Making And Using Same | 2018-12-13 |
20180353423 | Cosmetic Compositions and Methods for Their Use in Firming Skin | 2018-12-13 |
20180353424 | CAMELLIA EXTRACT, ITS PREPARATION METHOD, AND ITS USE | 2018-12-13 |
20180353425 | METHODS OF TREATMENT OF CANCER BY CONTINUOUS INFUSION OF COENZYME Q10 | 2018-12-13 |
20180353426 | BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF | 2018-12-13 |
20180353427 | TWO-LAYER OCULAR IMPLANT | 2018-12-13 |
20180353428 | PEPTIDE HYDROGEL PROPERTIES AND ITS APPLICATIONS | 2018-12-13 |
20180353429 | PRODUCT COMPRISING HYDROLIZED COLLAGEN AND AT LEAST ONE AMORPHOUS MICRONIZED DRUG, PROCESS FOR THE PREPARATION THEREOF AND RELATED USES IN MEDICAL FIELD | 2018-12-13 |
20180353430 | AMORPHOUS POWDER COMPRISING AN ANGIOTENSIN RECEPTOR BLOCKER AND A NEUTRAL ENDOPEPTIDASE INHIBITOR | 2018-12-13 |
20180353431 | BIOERODIBLE DRUG DELIVERY DEVICES | 2018-12-13 |
20180353432 | SOFT GELATIN CAPSULES WITH pH-INDEPENDENT RELEASE | 2018-12-13 |
20180353433 | MULTIPHASIC PARTICLES FABRICATED BY WETTABILITY ENGENDERED TEMPLATED SELF-ASSEMBLY (WETS) METHODS | 2018-12-13 |
20180353434 | NUCLEIC ACID-CONTAINING LIPID NANOPARTICLES | 2018-12-13 |
20180353435 | POLYMER-LIPID MATERIALS FOR DELIVERY OF NUCLEIC ACIDS | 2018-12-13 |
20180353436 | COMPOSITIONS FOR MODULATED RELEASE OF PROTEINS AND METHODS OF USE THEREOF | 2018-12-13 |
20180353437 | KETAMINE TRANSDERMAL DELIVERY SYSTEM | 2018-12-13 |
20180353438 | EXOTHERMIC TOPICAL DEVICES FOR DELIVERING PHARMACEUTICALS AND COSMETICS TO THE SKIN | 2018-12-13 |
20180353439 | Pimarane Diterpenoids for Use in Cancer Treatment | 2018-12-13 |
20180353440 | Pimarane Diterpenoids for Use in Wound Healing and Angiogenesis | 2018-12-13 |
20180353441 | COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES | 2018-12-13 |
20180353442 | Beta-Hydroxyketones as topical active ingredients for the prevention or treatment of photodermatoses | 2018-12-13 |
20180353443 | CURCUMIN-BASED COMPOSITIONS & METHODS OF USE THEREOF | 2018-12-13 |
20180353444 | Composition for Preventing and/or Treating Cardiovascular and Cerebrovascular Diseases | 2018-12-13 |
20180353445 | METHODS AND COMPOSITIONS RELATING TO PROTEASOME INHIBITOR RESISTANCE | 2018-12-13 |
20180353446 | COMPOSITIONS AND METHODS OF TREATING AND/OR PREVENTING CANCER | 2018-12-13 |
20180353447 | BUTYRATE SALTS FOR USE IN INFLAMMATORY DISEASES | 2018-12-13 |
20180353448 | ANTISEPTIC, ANTISEBORRHEIC AND EXFOLIATING COMPOSITION TO REMOVE OR PREVENT ACNE | 2018-12-13 |
20180353449 | DRUG COMBINATION WITH ANTITUMOR EFFECTS | 2018-12-13 |
20180353450 | METHODS AND COMPOSITIONS FOR TREATING DEMYELINATING DISEASES USING SOBETIROME OR A SOBETIROME PRODRUG AND A PPAR ACTIVATOR | 2018-12-13 |
20180353451 | BROMFENAC BIOAVAILABILITY | 2018-12-13 |
20180353452 | Methods of Treating or Alleviating Mental Disorders and Associated Symtoms | 2018-12-13 |
20180353453 | LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS | 2018-12-13 |
20180353454 | Method for Using Small Molecule Compounds to Induce Human Tumor Cells to Be Directly Reprogrammed Into Non-Oncogenic Cells | 2018-12-13 |
20180353455 | MEDIUM CHAIN TRIGLYCERIDE COMPOSITIONS | 2018-12-13 |
20180353456 | COMPOSITION PREVENTING BACTERIAL INFLAMMATION IN MONOGASTRIC ANIMALS | 2018-12-13 |
20180353457 | ABIETANE DITERPENOID 7-ACETOXYROYLEANONES FOR USE IN CANCER TREATMENT | 2018-12-13 |
20180353458 | COMPOSITIONS CONTAINING PHEROMONES FOR TREATING BEHAVIOURAL OR MEDICAL PROBLEMS LINKED TO THE STRESS OF NON-HUMAN MAMMALS | 2018-12-13 |
20180353459 | PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN | 2018-12-13 |
20180353460 | METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs | 2018-12-13 |
20180353461 | USE OF CANNABINOIDS AS CERAMIDE-GENERATING ANTICANCER AGENTS IN TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES | 2018-12-13 |
20180353462 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS | 2018-12-13 |
20180353463 | Cannabinoid Formulations | 2018-12-13 |
20180353464 | COMPOSITION FOR BLOCKING ANGIOGENESIS | 2018-12-13 |
20180353465 | TANNIN-CONTAINING GASTROINTESTINAL FORMULATIONS AND METHODS OF USE | 2018-12-13 |
20180353466 | PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER | 2018-12-13 |
20180353467 | METHODS FOR TREATING ANGIOGENESIS RELATED DISORDER | 2018-12-13 |
20180353468 | MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER | 2018-12-13 |
20180353469 | USE OF COMPOSITION OF MULTIVITAMIN IN PREPARING DRUG FOR STIMULATING GASTROINTESTINAL SYSTEM MOTILITY | 2018-12-13 |
20180353470 | METHODS FOR REDUCING OR PREVENTING CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE II DIABETES MELLITUS | 2018-12-13 |
20180353471 | LIMITED RELEASE LINGUAL THIOCTIC ACID DELIVERY SYSTEMS | 2018-12-13 |
20180353472 | UNIT DOSE FORMULATIONS FOR USE AS AN ANTI-FUGETACTIC AGENT | 2018-12-13 |
20180353473 | USE OF AMISULPRIDE AS AN ANTI-EMETIC | 2018-12-13 |
20180353474 | METHOD FOR PREVENTING AND/OR TREATING AGING-ASSOCIATED COGNITIVE IMPAIRMENT AND NEUROINFLAMMATION | 2018-12-13 |
20180353475 | Erythropoietin Expression Promoter | 2018-12-13 |
20180353476 | C5-SUBSTITUTED CARBAPENEM ANTIBIOTICS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF USE IN TREATMENT OF MYCOBACTERIUM TUBERCULOSIS AND NON-TUBERCULAR MYCOBACTERIA | 2018-12-13 |
20180353477 | 5-HT6 RECEPTOR ANTAGONISTS FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE IN PATIENT SUBPOPULATION CARRYING APOE4 ALLELES | 2018-12-13 |
20180353478 | CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES | 2018-12-13 |
20180353479 | BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AN AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2018-12-13 |
20180353480 | ISOXAZOLIDINE DERIVED INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE 1 (RIPK1) | 2018-12-13 |
20180353481 | Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists | 2018-12-13 |
20180353482 | MIRABEGRON FOR THE TREATMENT OF RETINAL DISEASES | 2018-12-13 |
20180353483 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INDOLEAMINE, 2, 3-DIOXYGENASE INHIBITION AND INDICATIONS THEREFOR | 2018-12-13 |
20180353484 | USAGE OF ACETAZOLAMIDE FOR TREATING ICH, PARTICULARLY HYPERGLYCEMIC ICH | 2018-12-13 |
20180353485 | Therapeutic Agent for Fibrodysplasia Ossificans Progressiva | 2018-12-13 |
20180353486 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DARIER DISEASE | 2018-12-13 |
20180353487 | METHODS OF TREATING KERATIN HYPERPROLIFERATION DISORDERS USING mTOR INHIBITORS | 2018-12-13 |
20180353488 | COMBINATION THERAPY FOR TREATMENT OF RESTENOSIS | 2018-12-13 |
20180353489 | Antibacterial Pharmaceutical Combination and Method for Treating Gram-Negative Bacteria Infections | 2018-12-13 |
20180353490 | INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST | 2018-12-13 |
20180353491 | METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY | 2018-12-13 |
20180353492 | NON-AROMATIC HETEROCYCLIC DERIVATIVE HAVING MGAT2 INHIBITORY ACTIVITY | 2018-12-13 |
20180353493 | TREATMENT METHOD BY COMBINED USE OF MDM2 INHIBITOR AND BTK INHIBITOR | 2018-12-13 |
20180353494 | ANIMAL PEST CONTROL METHOD | 2018-12-13 |
20180353495 | PHARMACEUTICAL COMBINATIONS COMPRISING A PI3K INHIBITOR FOR THE TREATMENT OF CANCER | 2018-12-13 |
20180353496 | FORMULATIONS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)M- ETHYL)-2,2-DIFLUOROACETAMIDE | 2018-12-13 |
20180353497 | NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS | 2018-12-13 |
20180353498 | REDUCING MEMORY LOSS IN MAMMALS SUFFERING FROM ALZHEIMER'S DISEASE | 2018-12-13 |
20180353499 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | 2018-12-13 |
20180353500 | ADMINISTRATION OF DEUTERATED CFTR POTENTIATORS | 2018-12-13 |
20180353501 | MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | 2018-12-13 |
20180353502 | CONTROLLED RELEASE HYDROCODONE FORMULATIONS | 2018-12-13 |
20180353503 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | 2018-12-13 |
20180353504 | LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF | 2018-12-13 |
20180353505 | COMPATIBLE SOLUTE OR SOLUTE MIXTURE FOR USE IN THE PREVENTION OR TREATMENT OF DISEASES HAVING BARRIER DEFECTS IN EPITHELIAL TISSUES | 2018-12-13 |
20180353506 | CERDULATINIB FOR TREATING HEMATOLOGICAL CANCERS | 2018-12-13 |
20180353507 | METHODS OF PREVENTING OR TREATING HYPOGLYCEMIA BY ADMINISTERING A GPR119 AGONIST | 2018-12-13 |
20180353508 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2018-12-13 |
20180353509 | AMINOTHIAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS | 2018-12-13 |
20180353510 | Treatment of Biliary Duct Cancer | 2018-12-13 |
20180353511 | Use of MTAP Inhibitors for the Treatment of Lung Disease | 2018-12-13 |
20180353512 | COMBINATION THERAPIES FOR TREATING B-CELL MALIGNANCIES | 2018-12-13 |
20180353513 | USES OF DPP IV INHIBITORS | 2018-12-13 |
20180353514 | METHODS OF TREATING BRAIN TUMORS USING COMBINATION THERAPY | 2018-12-13 |
20180353515 | TREATMENT OF CANCER WITH A PI3K INHIBITOR IN A PATIENT PRESSELECTED FOR HAVING A PIK3CA MUTATION IN THE CTDNA | 2018-12-13 |
20180353516 | METHODS OF TREATING PRURITUS | 2018-12-13 |
20180353517 | METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES | 2018-12-13 |
20180353518 | OPHTHALMIC SOLUTIONS | 2018-12-13 |